On July 14, 2025, the FTC announced its enforcement action against telemedicine company NextMed over charges it used misleading prices, fake reviews and deceptive weight-loss claims to sell GLP-1 weight-loss drugs. The FTC has now settled its charges that NextMed used deceptive practices to lure consumers into buying their weight-loss membership programs that had hidden terms and conditions. With the rise of both authentic and counterfeit GLP-1s throughout the nation and the proliferation of the availability of GLP-1s from telemedicine/telehealth companies, online pharmacies and medspas, this announcement is a sign that the federal government will actively monitor these entities to ensure consumers are getting genuine, authentic GLP-1s, that consumers are making informed decisions about weight-loss drugs, and that consumers are not being deceived and duped in the frenzy over GLP-1s.

Continue Reading FTC Uses Its Consumer Protection Powers to Regulate Sellers of GLP-1s

Merger consent orders have returned to the FTC, with the agency’s latest decision highlighting how the current leadership is evaluating divestiture proposals. The FTC has approved a proposed consent agreement in Alimentation Couche-Tard Inc.’s (ACT) acquisition of retail fuel outlets from Giant Eagle, Inc. that paired standard retail divestitures with a “prior notice” requirement that

Just like the D.C. weather, the FTC’s docket was hot this past week. The agency (1) shared updates on settlements requiring refunds to consumers in a number of recent actions; (2) announced the reopening of its “Epic” settlement claim process; and (3) announced several new settlements the agency has reached in both the competition and consumer protection spaces; in some of these, the Commissioners issued statements, allowing readers a glimpse into the minds of the enforcers and decision makers themselves. These stories and more after the jump.

Continue Reading FTC Updates (June 23 – 27, 2025)

The FTC is heading into summer with an active docket. The agency has been keeping its eye on enforcement, issuing warning letters to contact lens prescribers over potential violations of the agency’s Contact Lens and Eyeglass Rules. Over the next few weeks, it plans on hosting a workshop on healthcare advertising and listening sessions on prescription drug pricing and competition. These stories, and more, after the jump. 

Continue Reading FTC Updates (May 26 – June 16, 2025)

Register now to join Stefan M. Meisner, Luke van Houwelingen, and Eric Fanchiang on June 4, 2025 from 12:00 pm EDT – 1:00 pm EDT as they discuss antitrust risks that can arise as companies grapple with whether and how to adjust their pricing to respond to tariffs being imposed around the world. The webinar is designed to give listeners an understanding of these potential risks, and best practices for companies to manage such risks and minimize scrutiny from antitrust regulators and potential litigants when developing their tariff responses.

Continue Reading Register Now! Antitrust Risks in A Trade War Webinar

This week, the FTC’s Bureau of Consumer Protection has been busy addressing the “Attention Economy,” false income claims, privacy and data security, and a student debt relief scam. On the competition side, the FTC enforced against raising prices for anesthesiology services. These stories, and more, after the jump.

Continue Reading FTC Blog Updates May 19 – May 23, 2025

Register now to join Joanna Rosen Forster, Joachim B. Steinberg, Preetha Chakrabarti, David Ervin, and Warrington Parker on June 11, 2025 from 12:00 pm EDT – 1:00 pm EDT as they discuss Section 230 and the implications for digital platforms, online businesses and e-commerce. Section 230 was enacted as part of the United States Communications Decency Act (CDA), providing immunity to interactive computer service providers for third-party content. Known as “the 26 words that created the internet,” this statute is responsible for the development of the modern internet as we know it. 

Recent calls by the DOJ, FTC, FCC, State AGs and even Congressional Leaders to reform, edit or take Section 230 enforcement in new directions signal a potential inflection point. The challenge for policy reform lies in balancing Section 230’s role in protecting online speech and fostering innovation with evolving concerns about platform accountability, consumer protection, and market efficiency in a data-driven economy.

Continue Reading Register Now! Section 230: Implications for Digital Platforms, Online Businesses and E-Commerce Webinar

On April 21, 2025, the FTC filed an enforcement action against Uber alleging that Uber enrolled consumers in Uber One without proper consent, created substantial barriers to cancellation, and misrepresented the financial benefits of the subscription. The claims include violations of the FTC Act—which prohibits unfair and deceptive acts in commerce—and the Restore Online Shoppers’ Confidence Act (“ROSCA”)—which prohibits charging consumers for goods and services sold on the internet through a negative option (i.e., failing to cancel a subscription, unless the seller clearly discloses all material terms of the transaction before obtaining the consumer’s information and obtains the consumer’s expressed informed consent for the charges and provides simple mechanisms for the consumer to stop the recurring charges). Click here to continue reading.

Continue Reading Three-Clicks You’re Out? The FTC’s Action Against Uber Showcases That Businesses Need to Provide Transparent Cancellation Processes

The FTC has remained active in both the antitrust and consumer protection spaces. The agency is seeking public comment about federal regulations that could themselves be harming competition in the economy. The Commission also released data and statistics about common text message scams. And, of course, the agency’s landmark trial against Meta continues. More information on these stories after the jump.

Continue Reading FTC Updates (April 14 – 18, 2025)